Touze A, Enogat N, Buisson Y, Coursaget P
Institut de Virologie de Tours and Laboratoire des Processus Infectieux et Tumoraux, Faculté des Sciences Pharmaceutiques "Philippe Maupas," 37200 Tours, France.
J Clin Microbiol. 1999 Feb;37(2):438-41. doi: 10.1128/JCM.37.2.438-441.1999.
Two hepatitis B core proteins bearing the immunodominant region of the hepatitis E virus (HEV) capsid protein, one at the C terminus of hepatitis B virus core antigen (HBcAg) and the other within the HBcAg immunodominant loop, were constructed. Both chimeric proteins exhibited HEV reactivity, but only the first construct retained HBcAg reactivity. The second construct was used to develop an anti-HEV test which is equivalent to a commercial test for the detection of anti-HEV immunoglobulin G (IgG) but is more sensitive for the detection of anti-HEV IgM.
构建了两种带有戊型肝炎病毒(HEV)衣壳蛋白免疫显性区的乙型肝炎核心蛋白,一种位于乙型肝炎病毒核心抗原(HBcAg)的C末端,另一种位于HBcAg免疫显性环内。两种嵌合蛋白均表现出对HEV的反应性,但只有第一种构建体保留了对HBcAg的反应性。第二种构建体用于开发一种抗HEV检测方法,该方法等同于用于检测抗HEV免疫球蛋白G(IgG)的商业检测方法,但对抗HEV IgM的检测更敏感。